We just got more 'hopeful' data on Gilead's potential coronavirus treatment, but it's too soon to tell if the drug works
2:23pm PDT - April 10th, 2020 remdesivir - Business InsiderMore than two-thirds of hospitalized COVID-19 patients improved in condition after receiving remdesivir, an experimental antiviral treatment from Gilead Sciences. These findings come from data published Friday on 53 patients, the largest dataset yet for remde…